123 results on '"W. Zhuang"'
Search Results
2. 320MO Envonalkib vs crizotinib in treatment-naïve advanced ALK-positive NSCLC: A randomized, multicenter, phase III trial
3. 69O First-line serplulimab versus placebo in combination with chemotherapy in PD-L1-positive oesophageal squamous cell carcinoma (ASTRUM-007): A randomised, double-blind, multicentre phase III study
4. 86P Efficacy and safety of IBI110 (anti-LAG-3 mAb) in combination with sintilimab (anti-PD-1 mAb) in advanced squamous non-small cell lung cancer (sqNSCLC): Updated results of the phase Ib study
5. OA03.07 Safety and Efficacy of D-1553 in Patients with KRAS G12C Mutated Non-Small Cell Lung Cancer: A Phase 1 Trial
6. 1017P AdvanTIG-105: Phase Ib dose-expansion study of ociperlimab (OCI) + tislelizumab (TIS) with chemotherapy (chemo) in patients (pts) with metastatic squamous (sq) and non-squamous (non-sq) non-small cell lung cancer (NSCLC)
7. 1022P A phase II study of KN046 (a bispecific anti-PD-L1/CTLA-4) in patients with metastatic non-small cell lung cancer (NSCLC) who failed first line treatment
8. EP08.02-139 A Phase 2 Study of Befotertinib in Patients with EGFR T790M Mutated NSCLC after Prior EGFR TKIs
9. P17.02 RATIONALE 307: A Subgroup Analysis of Tislelizumab Plus Chemo vs Chemo Alone As 1L Treatment for Stage IIIB Advanced Sq NSCLC
10. 8MO The efficacy and safety of TQ-B3101 monotherapy in the first-line treatment in patients with ROS1-positive non-small cell lung cancer
11. Conjunctive water management under multiple uncertainties: A centroid-based type-2 fuzzy-probabilistic programming approach
12. FP04.03 Dynamic Liquid Biopsy for Selecting Advanced NSCLC Patients for Primary Tumor Resection After Targeted Therapy
13. P57.01 Prevalence MSH6 Mutations in East Asian Non-Small Cell Lung Cancer Patients
14. P53.07 Clinicopathologic Characteristics of Patients With PTPN11 Mutations in East Asian Non-Small Cell Lung Cancer Patients
15. P70.01 Distribution of CCND1 Mutations in East Asian Patients With Non-Small Cell Lung Cancer
16. Analyzing climate change impacts on water resources under uncertainty using an integrated simulation-optimization approach
17. 1297P RATIONALE 307: Tislelizumab (TIS) plus chemotherapy (chemo) vs chemo alone as first-line (1L) treatment for advanced squamous non-small cell lung cancer (sq NSCLC) in patients (pts) who were smokers vs non-smokers
18. Assessment of uncertainty effects on crop planning and irrigation water supply using a Monte Carlo simulation based dual-interval stochastic programming method
19. P70.05 The Association Between MAP2K1 Mutation Class and Clinical Features in MAP2K1-Mutant East Asian Non-Small Cell Lung Cancer Patients
20. P59.01 AR Mutations Defines a Unique Molecular Class of Non-Small Cell Lung Cancer in East Asian Patients
21. P70.04 Outcomes of Molecular Characteristics in East Asian IDH2-mutant Non-Small Cell Lung Cancer Patients
22. P73.01 Clinicopathologic Characteristics and Survival Outcome in East Asian Patients With Non-Small Cell Lung Cancer and FGFR2 Mutations
23. P55.01 Different Types of CDK4 Mutations in East Asian Non-Small Cell Lung Cancer Patients
24. P70.03 Molecular Characterization of AKT1 Gene in East Asian Non-Small Cell Lung Cancer Patients
25. P70.02 Clinicopathologic Characteristics and Outcomes of East Asian Patients With Non-Small-Cell Lung Cancer and FLT3 Mutations
26. MicroCT angiography detects vascular formation and regression in skin wound healing
27. EP1.03-01 Molecular Spectrum of Patients with JAK1 Mutations in East Asian Non-Small Cell Lung Cancer
28. P1.03-47 KEAP1 Mutations in East Asian Patients with NSCLC: An Investigation of Prevalence, Clinicopathologic Characteristics and Prognosis
29. EP1.03-09 Epidemiological Study of TSC1 Mutations Among Non-Small Cell Lung Cancer Patients in China
30. EP1.03-03 Association Between Molecular Spectrum of EZH2 Variants and Prognosis in Patients with Non-Small-Cell Lung Cancer in Chinese Patients
31. EP1.03-28 Frequency and Molecular Characteristics of BRCA1 Mutations in Non-Small Cell Lung Cancer from East Asian Patients
32. EP1.03-14 Clinicopathologic Characteristics and Outcomes of Chinese Patients with Non-Small-Cell Lung Cancer and INPP4B Mutations
33. EP1.14-47 Lung Adenocarcinoma with Concurrent KRAS Mutation and ALK Rearrangement Responding to Crizotinib
34. The prevalence and prognostic significance of JAK2 mutation subtypes in non-small cell lung cancer from Chinese populations
35. Deep surface rolling for fatigue life enhancement of laser clad aircraft aluminium alloy
36. Primary resistance mechanisms revealed in Asian TKI-sensitizing EGFR mutations NSCLC patient populations
37. P3.03-09 Molecular Spectrum of KIT Mutations Detection in Chinese Non-Small Cell Lung Cancer Patients
38. P1.03-03 Molecular Characteristics of Chinese Patients with TSC2-Mutated Non-Small-Cell Lung Cancer: A Retrospective Study
39. P1.03-23 The Molecular Landscape and Outcome of Chinese Patients with Non-Small Cell Lung Cancer Harboring NTRK1 Point Mutations: A Retrospective Study
40. P1.03-26 Analysis of DDR2 Gene Aberrations in Chinese Non-Small-Cell Lung Cancer Patients and Evaluation of Their Prognosis
41. P1.03-08 Detection of PTCH1 Gene Variants in Non-Small Cell Lung Cancer Patients from China
42. A multicenter study of NRG1 fusions in Chinese non-small cell lung cancer patients and response to afatinib using next generation sequencing
43. EP1.03-24 Clinicopathologic Characteristics and Survival Outcome in Chinese Patients with Non-Small Cell Lung Cancer and HGF Mutations
44. EP1.03-17 Outcomes of Molecular Characteristics in Chinese BAP1-Mutant Non-Small Cell Lung Cancer Patients
45. EP1.14-46 The KIF5B-RET Fusion as a Novel Mechanism of Acquired EGFR Tyrosine Kinase Inhibitor Resistance in Lung Adenocarcinoma
46. EP1.16-34 Survival Analysis of Icotinib for Brain Metastases in EGFR Mutated Non-Small Cell Lung Cancer
47. EP1.03-35 Prevalence, Clinicopathologic Characteristics, and Molecular Associations of IGF1R Mutations in East Asian Patients with NSCLC
48. EP1.03-07 Prevalence and Clinicopathological Characteristics of EIF1AX Mutations in Chinese Patients with Non-Small Cell Lung Cancer
49. EP1.03-19 The Frequency and Prognosis of MDM2 Mutations in East Asian Non-Small-Cell Lung Cancer Patients
50. EP1.03-06 POLD1 Mutations Define a Unique Molecular Class of Non-Small Cell Lung Cancer in Chinese Patients
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.